LFG
DAWN

Larson Financial Group’s Day One Biopharmaceuticals DAWN Stock Holding History

Larson Financial Group’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$21.9K Hold
1,022
– – ﹤0.01% 1790
2025
Q4 		$9.53K Buy
1,022
+1,018
+25,450% +$8.51K ﹤0.01% 2141
2025
Q3 		$28 Buy
+4
New +$28 ﹤0.01% 3383
2025
Q2 		– Sell
-76
Closed -$603 – 3334
2025
Q1 		$603 Buy
+76
New +$819 ﹤0.01% 2525

Other funds holding DAWN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Larson Financial Group's DAWN Position: Q1 2026 in Review

Larson Financial Group held its Day One Biopharmaceuticals (DAWN) position steady in Q1 2026 at 1,022 shares worth $21.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1790.

Larson Financial Group first reported a position in DAWN in Q1 2025 and has held it in 4 quarters since. 206 funds tracked by Wall St. Rank hold DAWN as of Q1 2026.

  • Larson Financial Group held 1,022 shares of Day One Biopharmaceuticals worth $21.9K as of Q1 2026.
  • Larson Financial Group left its Day One Biopharmaceuticals share count unchanged in Q1 2026.
  • Day One Biopharmaceuticals made up ﹤0.01% of Larson Financial Group's portfolio in Q1 2026, its #1790 holding.
  • Larson Financial Group first reported a position in Day One Biopharmaceuticals in Q1 2025 and has held it in 4 quarters since.
  • 206 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q1 2026.

Based on Larson Financial Group's 13F filing for Q1 2026, filed 15 May 2026.